Rethink your Strategic Agendas and Operations Efforts

Key questions to prepare pharma operations to drive emerging markets growth

If a company is to be successful in pursuing opportunities with emerging middle-class groups worldwide, its leadership team must be confident that it can serve those groups in economically viable ways. 

When the appropriate operations strategy, distribution channels, low-cost footprint, and competencies are not in place, it will be necessary to envision and develop innovative new models that can do the job.

So how can big pharma executives rethink their strategic agendas and operations efforts so that they can reach the markets that will reward their organizations over the long term? 

They should consider the following questions:

• Do we have the right product design and packaging?
• Do we have the right manufacturing footprint?
• Do we have the right distribution approach?
• How do we ensure product quality?
• Can we leverage more broadly what we develop for emerging markets?
• Are we taking on too much risk in producing for emerging markets?
• Is our Operations organization ready for emerging markets?

(Abstract from the source: “Tapping Operations to Win Emerging Markets: Questions Every Pharma Executive Should Consider” by Ulf Schrader and Sabine Schulz │ Published source: ‘Operations for the Executive Suite: Opening new horizons for current and future pharma leaders’ │ A Book by McKinsey & Company │ 2012)